Document is current

Any future updates will be listed below

Galcanezumab bei therapierefraktären Migränepatienten rasch und anhaltend wirksam

Crossref DOI link: https://doi.org/10.1007/s00940-021-3182-6

Published Online: 2021-07-26

Published Print: 2021-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark